Privia Health Gr Analyst Price Targets

Wall Street analyst price targets and consensus rating for Privia Health Gr (PRVA).

Price Target Range — 11 Quarters

Analyst Consensus — 20 Analysts

3S.Buy

16Buy

1Hold

Consensus RatingOutperform# Analysts20Avg. Consensus PT$29Upside to Avg. PT+38.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
May 26, 2026	Barclays	Andrew Mok	PT Cut	Equal-Weight	$25→$24
May 8, 2026	Canaccord Genuity	Richard Close	PT Cut	Buy	$35→$34
Apr 8, 2026	Evercore ISI Group	Elizabeth Anderson	PT Cut	Outperform	$30→$26
Mar 25, 2026	Barclays	Andrew Mok	PT Raise	Equal-Weight	$23→$25
Mar 3, 2026	Citigroup	Daniel Grosslight	PT Cut	Buy	$34→$32
Mar 2, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$31→$33
Feb 27, 2026	Canaccord Genuity	Richard Close	PT Raise	Buy	$34→$35
Jan 9, 2026	RBC Capital	Ryan Halsted	Reinstates	Outperform	$31
Dec 4, 2025	Stephens & Co.	Jeff Garro	Maintained	Overweight	$32
Nov 13, 2025	JP Morgan	Lisa Gill	PT Raise	Overweight	$32→$33
Nov 13, 2025	BMO Capital	Sean Dodge	Initiate	Outperform	$30
Nov 12, 2025	Canaccord Genuity	Richard Close	PT Raise	Buy	$32→$34
Nov 10, 2025	Barclays	Andrew Mok	PT Raise	Equal-Weight	$22→$23
Nov 10, 2025	Truist Securities	Jailendra Singh	PT Raise	Buy	$30→$31
Nov 7, 2025	Evercore ISI Group	Elizabeth Anderson	PT Raise	Outperform	$28→$30
Nov 7, 2025	Citizens	Constantine Davides	PT Raise	Market Outperform	$30→$31
Oct 9, 2025	Barclays	Andrew Mok	PT Raise	Equal-Weight	$21→$22
Sep 24, 2025	Stephens & Co.	Jeff Garro	Maintained	Overweight	$32
Sep 4, 2025	Stephens & Co.	Jeff Garro	Maintained	Overweight	$32
Aug 29, 2025	JMP Securities	David M. Scharf	PT Raise	Market Outperform	$29→$30

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $34

Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $35 to $34.

Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on Privia Health Gr, Lowers Price Target to $26

Evercore ISI Group analyst Elizabeth Anderson maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and lowers the price target from $30 to $26.

Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $25

Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and raises the price target from $23 to $25.

Benzinga Newsdesk

Breaking Down Privia Health Gr: 5 Analysts Share Their Views

Benzinga Insights

PRO
Citigroup Maintains Buy on Privia Health Gr, Lowers Price Target to $32

Citigroup analyst Daniel Grosslight maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $34 to $32.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Privia Health Gr, Raises Price Target to $33

Truist Securities analyst Jailendra Singh maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and raises the price target from $31 to $33.

Benzinga Newsdesk

Privia Health Group Inc

Privia Health Gr Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $34

PRO
Evercore ISI Group Maintains Outperform on Privia Health Gr, Lowers Price Target to $26

PRO
Barclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $25

Breaking Down Privia Health Gr: 5 Analysts Share Their Views

PRO
Citigroup Maintains Buy on Privia Health Gr, Lowers Price Target to $32

PRO
Truist Securities Maintains Buy on Privia Health Gr, Raises Price Target to $33

People Also Watch

People Also Watch

Benzinga

Benzinga

Privia Health Group Inc

Privia Health Gr Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCanaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $34

PROEvercore ISI Group Maintains Outperform on Privia Health Gr, Lowers Price Target to $26

PROBarclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $25

Breaking Down Privia Health Gr: 5 Analysts Share Their Views

PROCitigroup Maintains Buy on Privia Health Gr, Lowers Price Target to $32

PROTruist Securities Maintains Buy on Privia Health Gr, Raises Price Target to $33

People Also Watch

People Also Watch

PRO
Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $34

PRO
Evercore ISI Group Maintains Outperform on Privia Health Gr, Lowers Price Target to $26

PRO
Barclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $25

PRO
Citigroup Maintains Buy on Privia Health Gr, Lowers Price Target to $32

PRO
Truist Securities Maintains Buy on Privia Health Gr, Raises Price Target to $33